Wendy Galbraith , Pharm. D, BCNP
Clinical Assistant Professor
Department of Pharmaceutical Sciences
Research Summary
Research Interest:
-
Enhancing the education and training experience required by the Nuclear Regulatory Commission (NRC) and the State Board of Oklahoma to be an Authorized Nuclear Pharmacist or an "authorized user" (AU) of radioactive materials.
-
Defining scope of practice, competency standards, and performance improvement parameters for nuclear pharmacists.
-
Improve and expand patient services of the OUHSC Nuclear Pharmacy to clinical areas to promote clinical research and advancement in nuclear medicine.
Clinical Expertise:
-
Nuclear Pharmacy and Radiopharmaceuticals. Development and growth of professional education in nuclear pharmacy. This includes overseeing all professional education in nuclear pharmacy including elective/selective course work in the doctor of pharmacy program (including Pharm.D./M.S.), pharmacy interns employed in the nuclear pharmacy, continuing professional education for nuclear pharmacists, board certification for nuclear pharmacists employed in the nuclear pharmacy, residency program in nuclear pharmacy, and nuclear pharmacy education for other health care professionals including but not limited to nuclear medicine technologists, nuclear medicine and radiology residents, and health physicists.
Certification
- Board of Pharmaceutcal Specialties, Board Certified Nuclear Pharmacist, 1996 to present
Licensures
- Registered Pharmacist (Arizona), 1990 to present
- Registered Pharmacist (Oklahoma), 1993 to present
Education & Experience
Education
- Doctor of Pharmacy, University of Oklahoma Health Sciences Center, OKC, OK, 1999-2003.
- Bachelor of Science, Pharmacy, University of Oklahoma Health Sciences Center, 1985-1990.
Professional Experience
- Clinical Assistant Professor and Professional Educational Coordinator in Nuclear Pharmacy, Department of Pharmaceutical Sciences, College of Pharmacy, OUHSC, OKC, OK 2007-present.
- Director of Nuclear Pharmacy, OU Medical Center/OUHSC College of Pharmacy, OKC, OK 2000-2007.
- Radiopharmacist, Staff Pharmacist, Syncor International Inc., Nashvile TN, Dallas TX, and OKC, OK. 1995-2000.
- Radiopharmacist, Staff Pharmacist, OU Medical Center/OUHSC Nuclear Pharmacy, OKC, OK. 1993-1995.
- Investigational New Drug & Clinical Pharmacist. Veterans Administration Medical Center, OKC, OK. 1992-1993.
- Radiopharmacist, Staff Pharmacist, Medi-Physics/Amersham, Phoenix, AZ. 1990-1992.
Honors & Service
Committees
- Board of Pharmaceutical Specialties, Role Delineation Committee, Nuclear Pharmacist Expert, 2007.
- Board of Pharmaceutical Specialties, Vice-Chair, 2006-present.
- Board of Pharmaceutical Specialties, Executive council member, 2005-present.
- APhA-APPM, Educational Committee, Section moderator, 2008.
- APhA-APPM, Regulatory Affairs Committee, 2006.
- Oklahoma State Board of Pharmacy, Compounding Committee, Sub-Committee Chair. 2008.
- Oklahoma Section of the Society of Nuclear Medicine, Ex-Officio CE Chair. 2007-2008.
Selected Publications & Presentations
-
Dormer KJ, Awasthi V, Galbraith W, Kopke RD, Chen K, Wassel R. Magnetically-targeted technetium 99m-labeled nanoparticles to the inner ear. J Biomed Nanotechnology 2008; 4(2): 174-184.
-
Lian Y, Chu RY, Galbraith WK, MacDurmon GW, Sonnad JR. Establishing a threshold for [131]I bioassay in nuclear medicine personnel. Operational Radiation Safety (ORS), August 2008.
-
"Mediation Use in the Radiology Department" Oklahoma Section of the Society of Nuclear Medicine; Oklahoma City. July 2008.
-
Dormer KJ, Awasthi V, Galbraith W, Kopke RD, chen K, Wassel R. Magnetically-targeted technetium 99m-labeled nanoparticles to the inner ear. J Biomed Nanotechnology 2008; 4(2):174-184(11).
-
Liang Y, Chu RY, Galbraith WK, MacDurmon GW, Sonnad JR. Establishing a threshold for [131]i bioassay in nuclear medicine personnel. Radiation Safety Journal 2008; 95 (suppl 5): S175-S179.